101 related articles for article (PubMed ID: 1974071)
1. Studies with alpidem in normal volunteers and anxious patients.
Morton S; Lader M
Pharmacopsychiatry; 1990 May; 23 Suppl 3():120-3. PubMed ID: 1974071
[TBL] [Abstract][Full Text] [Related]
2. Alpidem and lorazepam in the treatment of patients with anxiety disorders: comparison of physiological and psychological effects.
Morton S; Lader M
Pharmacopsychiatry; 1992 Jul; 25(4):177-81. PubMed ID: 1356277
[TBL] [Abstract][Full Text] [Related]
3. Effects of single doses of alpidem, lorazepam, and placebo on memory and attention in healthy young and elderly volunteers.
Satzger W; Engel RR; Ferguson E; Kapfhammer H; Eich FX; Hippius H
Pharmacopsychiatry; 1990 May; 23 Suppl 3():114-9. PubMed ID: 1974070
[TBL] [Abstract][Full Text] [Related]
4. On the therapeutic action of alpidem in anxiety disorders: an overview of the European data.
Morselli PL
Pharmacopsychiatry; 1990 May; 23 Suppl 3():129-34. PubMed ID: 1974073
[TBL] [Abstract][Full Text] [Related]
5. Assessment of the interaction between a partial agonist and a full agonist of benzodiazepine receptors, based on psychomotor performance and memory, in healthy volunteers.
Patat A; Perault MC; Vandel B; Danjou P; Brohier S; Zieleniuk I; Rosenzweig P
J Psychopharmacol; 1995 Jan; 9(2):91-101. PubMed ID: 22298734
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
Diamond BI; Nguyen H; O'Neal E; Ochs R; Kaffeman M; Borison RL
Psychopharmacol Bull; 1991; 27(1):67-71. PubMed ID: 1677774
[TBL] [Abstract][Full Text] [Related]
7. Alpidem, a novel anxiolytic drug. A double-blind, placebo-controlled study in anxious outpatients.
Bassi S; Albizzati MG; Ferrarese C; Frattola L; Cesana B; Piolti R; Farolfi A
Clin Neuropharmacol; 1989 Feb; 12(1):67-74. PubMed ID: 2565767
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
[TBL] [Abstract][Full Text] [Related]
9. [Double-blind versus placebo comparison of single dose alpidem (50 mg or 75 mg) in a model of situational anxiety].
Regnier F; Chastel A; L'Heritier C; Magni G; Henry M
Therapie; 1989; 44(4):279-83. PubMed ID: 2574502
[TBL] [Abstract][Full Text] [Related]
10. Alpidem and psychological performance in elderly subjects.
Hindmarch I
Pharmacopsychiatry; 1990 May; 23 Suppl 3():124-8. PubMed ID: 1974072
[TBL] [Abstract][Full Text] [Related]
11. Effects of alpidem in anxious elderly outpatients: a double-blind, placebo-controlled trial.
Frattola L; Piolti R; Bassi S; Albizzati MG; Cesana BM; Bottani MS; Priore P; Borghi C; Morselli PL
Clin Neuropharmacol; 1992 Dec; 15(6):477-87. PubMed ID: 1362137
[TBL] [Abstract][Full Text] [Related]
12. Double blind, controlled study of the efficacy and safety of alpidem in the treatment of anxiety in schizophrenic in-patients.
Minervini MG; Priore P; Farolfi A; Cesana B; Morselli PL
Pharmacopsychiatry; 1990 Mar; 23(2):102-6. PubMed ID: 1971117
[TBL] [Abstract][Full Text] [Related]
13. Performance impairment and increased anxiety resulting from the combination of alcohol and lorazepam.
Lister RG; File SE
J Clin Psychopharmacol; 1983 Apr; 3(2):66-71. PubMed ID: 6132935
[TBL] [Abstract][Full Text] [Related]
14. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
Lemoine P; Touchon J; Billardon M
Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
[TBL] [Abstract][Full Text] [Related]
16. The effects of single doses of alpidem and lorazepam on memory and psychomotor performance in normal humans.
Curran HV; Allen D; Lader M
J Psychopharmacol; 1987 Jan; 1(2):81-9. PubMed ID: 22158888
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of the interaction of alcohol with alpidem, lorazepam and placebo in normal subjects.
Allen D; Baylav A; Lader M
Int Clin Psychopharmacol; 1988 Oct; 3(4):327-41. PubMed ID: 3235818
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological and behavioral profile of alpidem as an anxiolytic.
Zivkovic B; Morel E; Joly D; Perrault G; Sanger DJ; Lloyd KG
Pharmacopsychiatry; 1990 May; 23 Suppl 3():108-13. PubMed ID: 1974069
[TBL] [Abstract][Full Text] [Related]
19. Clinical studies with the new anxiolytic alpidem in anxious patients: an overview of the European experiences.
Musch B; Morselli PL; Priore P
Pharmacol Biochem Behav; 1988 Apr; 29(4):803-6. PubMed ID: 2901120
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytics' effects on the actual driving performance of patients and healthy volunteers in a standardized test. An integration of three studies.
O'Hanlon JF; Vermeeren A; Uiterwijk MM; van Veggel LM; Swijgman HF
Neuropsychobiology; 1995; 31(2):81-8. PubMed ID: 7760989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
